Craft
  • Home
  •  / Twist Bioscience
Twist Bioscience

Twist Bioscience

Customers

2.9 K

FY, 2021

Revenue

$203.6 M

FY, 2022

Market Capitalization

$1.3 B

2023-01-13

Twist Bioscience Summary

Company summary

Overview
Twist Bioscience is a synthetic biology company that develops a proprietary silicon-based manufacturing process for the production of synthetic DNA. It offers synthetic genes, tools for next-generation sample preparation, antibody libraries for drug discovery and development, oligo pools, and other products. The company also provides a semiconductor-based platform that miniaturizes the chemistry necessary for DNA synthesis. Twist Bioscience serves the medicine, agriculture, industrial chemicals, and data storage markets.
Type
Public
Status
Active
Founded
2013
HQ
South San Francisco, CA, US | view all locations
Website
https://www.twistbioscience.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Emily Leproust
  • Jim Thorburn

    Jim Thorburn, Chief Financial Officer

  • Patrick Finn

    Patrick Finn, Chief Commercial Officer

  • Aaron Sato

    Aaron Sato, Chief Scientific Officer

Operating MetricsView all

Customers

2.9K
31.8%

FY, 2021

Synthetic DNA Users

100K

FY, 2020

Number of Genes Shipped

372.3K
10.0%

FY, 2021

LocationsView all

5 locations detected

  • South San Francisco, CA HQ

    United States

    681 Gateway Blvd

  • Carlsbad, CA

    United States

    5600 Avenida Encinas Suite 140D-2

  • Guangzhou

    China

    Guanzhou Life Science Innovation Center North Tower, Second Floor, Room 203

  • Tel Aviv-Yafo, Tel Aviv District

    Israel

    Rothschild Blvd 3

  • Singapore

    Singapore

    3 Fusionopolis Pl

Twist Bioscience Financials

Summary financials

Revenue (FY, 2022)
$203.6M
Gross profit (FY, 2022)
$84.2M
Net income (FY, 2022)
($217.9M)
Cash (FY, 2022)
$378.7M
EBIT (FY, 2022)
($234.8M)
Enterprise value
$1.0B

Footer menu